tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Rain Oncology reports Q4 EPS (70c), consensus (56c)

The company said, "As of December 31, 2022, Rain had $130.5M in cash, cash equivalents and short-term investments. Rain will not provide guidance on cash runway at this time. Rain will continue to assess its cash runway and provide further guidance, if appropriate, after the release of MANTRA topline results in the second quarter of this year."

Elevate Your Investing Strategy:

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on RAIN:

Disclaimer & DisclosureReport an Issue

1